Pfizer 90% effective in preventing COVID-19 in teenagers

被引：0
|
作者：
不详
机构：
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2021年 / 215卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：440 / 440
页数：1
相关论文
共 50 条
  • [21] Preventing the digital scars of COVID-19
    Marabelli, Marco
    Vaast, Emmanuelle
    Li, Jingyao Lydia
    EUROPEAN JOURNAL OF INFORMATION SYSTEMS, 2021, 30 (02) : 176 - 192
  • [22] Ivermectin for preventing and treating COVID-19
    Popp, Maria
    Stegemann, Miriam
    Metzendorf, Maria-Inti
    Gould, Susan
    Kranke, Peter
    Meybohm, Patrick
    Skoetz, Nicole
    Weibel, Stephanie
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (07):
  • [23] Preventing COVID-19 prejudice in academia
    Rzymski, Piotr
    Nowicki, Michal
    SCIENCE, 2020, 367 (6484) : 1313 - 1313
  • [24] Neurological Complications of COVID-19: Guillain-Barre Syndrome Following Pfizer COVID-19 Vaccine
    Waheed, Sadia
    Bayas, Angel
    Hindi, Fawzi
    Rizvi, Zufe
    Espinosa, Patricio S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [25] Covid-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 375 : n2713
  • [26] Covid-19: Oxford vaccine is up to 90% effective, interim analysis indicates
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4564
  • [27] Covid-19: Pfizer and BioNTech submit vaccine for US authorisation
    Mahase, Elisabeth
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371 : m4552
  • [28] Booster Dose of the Pfizer/BioNTech COVID-19 Vaccine (Comirnaty)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1635): : 161 - 162
  • [29] COVID-19 Pfizer's vaccine raises allergy concerns
    de Vrieze, Jop
    SCIENCE, 2021, 371 (6524) : 10 - +
  • [30] COVID-19 pandemic-related anxiety in teenagers
    Sahoo, Swapnajeet
    Rani, Seema
    Shah, Ruchita
    Singh, Ajay Pal
    Mehra, Aseem
    Grover, Sandeep
    INDIAN JOURNAL OF PSYCHIATRY, 2020, 62 (03) : 328 - 330
12345